Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00204815 · ClinicalTrials.gov registry record
Bone Mineral Density in Pediatric Epilepsy
A clinical trial, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- 98
- Enrollment target
NCT00204815: Completed study, sponsored by University of Wisconsin, Madison.
NCT00204815 is a clinical trial that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 98 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00204815 has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- 98 participants
- Enrollment target
Study Summary
What are the effects of the currently used AEDs on bone mineralization in children and adolescents between the ages of 8 to 18? This is a pilot observational study using DEXA scans to measure bone mineral density in 100 patients The primary objective is to collect preliminary data on bone mineral density, body weight, dietary calcium intake, and activity level.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 98 participants |
| Start Date | 2005-01 |
| Est. Completion | 2007-10 |
What the finished NCT00204815 record still lists
NCT00204815 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 98 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00204815 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00204815 about?
NCT00204815 is a clinical study titled "Bone Mineral Density in Pediatric Epilepsy". What are the effects of the currently used AEDs on bone mineralization in children and adolescents between the ages of 8 to 18? This is a pilot observational study using DEXA scans to measure bone mineral density in 100 patients The primary objective is to collect preliminary data on bone mineral de...
What is the current status of trial NCT00204815?
This trial is currently completed. The enrollment target is 98 participants. The study started on 2005-01. Estimated completion is 2007-10.
Who is sponsoring clinical trial NCT00204815?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02926729 · 98 participants · NA
Real-Time Assessment Of Breast Cancer Lumpectomy Specimen Margins With Nonlinear Microscopy
- NCT03382977 · 98 participants · Phase 1
Study to Evaluate Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBI-1901 in Recurrent GBM Subjects
- NCT04577014 · 98 participants · Phase 1
Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue Sarcoma
- NCT04817618 · 98 participants · Phase 3
Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia